MedTechIntelligence report

Obstructive sleep apnea hides in a large cardiometabolic population

Undiagnosed sleep-disordered breathing creates downstream risk across cardiovascular disease, metabolic health, daytime function, and device-adherence workflows.

epidemiologydisease burdenopportunity sizingtherapeutic areas
Obstructive sleep apnea hides in a large cardiometabolic population

What this report covers

  • Undiagnosed sleep-disordered breathing creates downstream risk across cardiovascular disease, metabolic health, daytime function, and device-adherence workflows.

Topics in this briefing

therapeutic-area asset packsburden-of-disease explainersmarket opportunity sizingdisease-state strategy

Sources

Source notes will appear here when included with the report.

Related reports

More on adjacent market questions.

Atrial fibrillation is a growing U.S. stroke-prevention burden

Projected prevalence, age-linked risk, hospitalizations, silent disease, and anticoagulation handoffs frame AFib as a population-scale rhythm-management problem.

epidemiologydisease burdenopportunity sizing
Intelligence reportJun 7, 2026
Diabetic foot ulcers concentrate cost, recurrence, and limb risk

A high-risk diabetes complication creates clinical and economic burden when neuropathy, PAD, infection, and follow-up gaps delay healing.

epidemiologydisease burdenopportunity sizing
Intelligence reportJun 7, 2026
Heart failure is becoming a cardiovascular-kidney-metabolic burden

U.S. prevalence, mortality, readmissions, aging, HFpEF, and multimorbidity frame HF as a chronic-care and transition-of-care problem.

epidemiologydisease burdenopportunity sizing
Intelligence reportJun 7, 2026